{
"@context": "https://schema.org",
"@type": "Article",
"headline": "US-UK Pharmaceutical Pricing Deal: UK agrees increase in amounts it can pay for innovative medicines and reduction of rebate rates",
"url": "https://www.lexblog.com/2025/12/02/us-uk-pharmaceutical-pricing-deal-uk-agrees-increase-in-amounts-it-can-pay-for-innovative-medicines-and-reduction-of-rebate-rates/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-SYFX7ATG",
"url": "https://www.lexblog.com/lib/SYFX7ATG/"
},
"datePublished": "2025-12-02T09:16:31-05:00",
"dateModified": "2025-12-03T04:34:07-05:00",
"author": {
"@type": "Person",
"name": "Adela Williams, Christopher Bates"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Arnold & Porter Kaye Scholer LLP"
},
"organizationScope": "at-publication",
"isPartOf": "BioSlice Blog",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.biosliceblog.com/?p=3892",
"sourceStability": "may-move"
}